In addition, BIRC3 is reported to improve the prognostication system in Chronic Lymphocytic Leukemia (Alhourani et al., 2016) and hepatocellular carcinoma patients undergoing curative resection (Fu et al., 2019). The gene discussed is BIRC3; the disease is B-cell chronic lymphocytic leukemia.